Health in Belgium
302 indicators covering health for Belgium.
| Indicator | Latest | Year | 10-yr change | Rank |
|---|---|---|---|---|
| Age population, age 25, male, interpolated | 70,276 | 2025 | down 4.1% | 91st |
| Age population, age 24, male, interpolated | 70,043 | 2025 | down 4.9% | 92nd |
| Age population, age 25, female, interpolated | 67,671 | 2025 | down 7.0% | 91st |
| Mortality rate, under-5 | 3.7 per 1,000 live births | 2024 | down 9.8% | 168th |
| Survival to age 65, male | 87.7% | 2024 | up 2.4% | 35th |
| Survival to age 65, female | 92.4% | 2024 | up 1.0% | 41st |
| Fertility rate, total | 1.44 births per woman | 2024 | down 17.2% | 165th |
| Life expectancy at birth, male | 80.3 years | 2024 | up 1.9% | 31st |
| Life expectancy at birth, total | 82.3 years | 2024 | up 1.2% | 31st |
| Life expectancy at birth, female | 84.4 years | 2024 | up 0.6% | 31st |
| Mortality rate, infant, male | 3.5 per 1,000 live births | 2024 | down 7.9% | 166th |
| Mortality rate, infant | 3.1 per 1,000 live births | 2024 | down 8.8% | 167th |
| Mortality rate, infant, female | 2.8 per 1,000 live births | 2024 | down 6.7% | 169th |
| Death rate, crude | 9.5 per 1,000 people | 2024 | up 2.2% | 50th |
| Birth rate, crude | 9.2 per 1,000 people | 2024 | down 17.9% | 168th |
| Mortality rate, adult, male | 73.08 per 1,000 male adults | 2024 | down 20.1% | 184th |
| Mortality rate, adult, female | 43.5 per 1,000 female adults | 2024 | down 18.3% | 181st |
| Immunization, Pol3 | 98.0% | 2024 | down 1.0% | 18th |
| Children per woman that survived childhood vs. those that died in childhood | 0.0068 under-five deaths per woman | 2024 | down 6.2% | 169th |
| Mortality rate, under-5, female | 3.3 per 1,000 live births | 2024 | down 10.8% | 169th |
| Mortality rate, under-5, male | 4.1 per 1,000 live births | 2024 | down 10.9% | 166th |
| Mortality rate, neonatal | 2.2 per 1,000 live births | 2024 | down 4.3% | 168th |
| Immunization, measles | 96.0% | 2024 | unchanged | 46th |
| Immunization, DPT | 97.0% | 2024 | down 2.0% | 29th |
| Life expectancy | 82.11 years | 2023 | up 2.0% | 35th |
| Lifetime risk of maternal death | 0.0% | 2023 | down 42.9% | 180th |
| Lifetime risk of maternal death | 21,405 1 in: rate varies by country | 2023 | up 75.2% | 15th |
| Number of maternal deaths | 4 | 2023 | down 42.9% | 141st |
| Maternal mortality ratio | 4 | 2023 | down 33.3% | 173rd |
| Probability of dying among children ages 5-9 years, female | 0.3 per 1,000 | 2024 | down 25.0% | 169th |
| Probability of dying among children ages 5-9 years, male | 0.4 per 1,000 | 2024 | down 20.0% | 168th |
| Probability of dying among adolescents ages 10-14 years, female | 0.3 per 1,000 | 2024 | down 25.0% | 185th |
| Probability of dying among adolescents ages 10-14 years, male | 0.4 per 1,000 | 2024 | down 33.3% | 185th |
| Probability of dying among adolescents ages 10-19 years, female | 1.1 per 1,000 | 2024 | down 15.4% | 177th |
| Probability of dying among adolescents ages 10-19 years, male | 1.6 per 1,000 | 2024 | down 30.4% | 190th |
| Probability of dying among adolescents ages 10-19 years | 1.4 per 1,000 | 2024 | down 22.2% | 186th |
| Probability of dying among adolescents ages 15-19 years, female | 0.7 per 1,000 | 2024 | down 22.2% | 179th |
| Probability of dying among adolescents ages 15-19 years, male | 1.2 per 1,000 | 2024 | down 29.4% | 190th |
| Probability of dying among youth ages 20-24 years, female | 1 per 1,000 | 2024 | down 9.1% | 176th |
| Probability of dying among youth ages 20-24 years, male | 2.2 per 1,000 | 2024 | down 29.0% | 180th |
| Women's share of population ages 15+ living with HIV | 33.5% | 2024 | down 2.4% | 92nd |
| Incidence of HIV, ages 15-49 | 0.1 per 1,000 uninfected population ages 15-49 | 2024 | down 9.1% | 98th |
| Incidence of HIV, all | 0.1 per 1,000 uninfected population | 2024 | unchanged | 77th |
| Prevalence of overweight, female | 46.8% | 2022 | up 5.4% | 127th |
| Prevalence of overweight, male | 55.3% | 2022 | down 3.7% | 100th |
| Prevalence of overweight | 51.1% | 2022 | up 0.2% | 120th |
| Immunization, HepB3 | 97.0% | 2024 | down 1.0% | 26th |
| Life expectancy at age 15 | 91.5 years | 2100 | up 1.2% | 34th |
| Incidence of HIV, ages 50+ | 0.01 per 1,000 uninfected population ages 50+ | 2024 | down 90.0% | 97th |
| Adults (ages 15+) and children (0-14 years) living with HIV | 19,000 | 2024 | up 26.7% | 82nd |
| Population ages 55-59, female | 6.5% | 2025 | down 1.6% | 54th |
| Population ages 15-19, female | 344,805 | 2025 | up 11.8% | 93rd |
| Population ages 70-74, female | 5.2% | 2025 | up 28.5% | 41st |
| Population ages 60-64, male | 6.8% | 2025 | up 14.1% | 29th |
| Population ages 80 and above, female | 7.0% | 2025 | up 1.3% | 22nd |
| Population ages 80 and above, male | 4.5% | 2025 | up 12.7% | 19th |
| Population ages 70-74, male | 283,349 | 2025 | up 40.1% | 45th |
| Population ages 60-64, female | 6.6% | 2025 | up 12.2% | 46th |
| Population ages 75-79, male | 3.9% | 2025 | up 24.7% | 23rd |
| Population ages 55-59, male | 6.8% | 2025 | up 0.5% | 39th |